Profile | GDS5420 / 221573_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 475.96 | 66 |
GSM1296119 | B_lesional_pre-dose | 305.12 | 59 |
GSM1296076 | C_lesional_pre-dose | 283.61 | 60 |
GSM1296092 | D_lesional_pre-dose | 339.36 | 62 |
GSM1296103 | E_lesional_pre-dose | 520.65 | 68 |
GSM1296078 | F_lesional_pre-dose | 212.29 | 55 |
GSM1296107 | G_lesional_pre-dose | 306.12 | 59 |
GSM1296109 | H_lesional_pre-dose | 409.95 | 64 |
GSM1296080 | I_lesional_pre-dose | 245.53 | 56 |
GSM1296090 | J_lesional_pre-dose | 231.95 | 56 |
GSM1296074 | K_lesional_pre-dose | 672.73 | 73 |
GSM1296111 | L_lesional_pre-dose | 283.96 | 58 |
GSM1296099 | M_lesional_pre-dose | 444.34 | 65 |
GSM1296086 | O_lesional_pre-dose | 318.7 | 61 |
GSM1296117 | P_lesional_pre-dose | 327.46 | 60 |
GSM1296113 | Q_lesional_pre-dose | 315.92 | 59 |
GSM1296096 | R_lesional_pre-dose | 439.93 | 66 |
GSM1296105 | S_lesional_pre-dose | 336.71 | 60 |
GSM1296098 | T_lesional_pre-dose | 424.04 | 65 |
GSM1296101 | U_lesional_pre-dose | 322.71 | 60 |
GSM1296121 | V_lesional_pre-dose | 363.6 | 62 |
GSM1296088 | W_lesional_pre-dose | 220.03 | 54 |
GSM1296082 | X_lesional_pre-dose | 282.53 | 59 |
GSM1296115 | Y_lesional_pre-dose | 311.13 | 59 |
GSM1296084 | Z_lesional_pre-dose | 338.69 | 61 |
GSM1296072 | B_lesional_day8 | 329.06 | 60 |
GSM1296069 | L_lesional_day8 | 307.86 | 58 |
GSM1296071 | P_lesional_day8 | 342.61 | 60 |
GSM1296070 | Y_lesional_day8 | 284.69 | 57 |
GSM1296073 | V_lesional_day8 | 357.66 | 63 |
GSM1296034 | A_lesional_day15 | 349.72 | 61 |
GSM1296041 | G_lesional_day15 | 333.93 | 61 |
GSM1296035 | R_lesional_day15 | 487.96 | 67 |
GSM1296038 | U_lesional_day15 | 327.01 | 60 |
GSM1296047 | B_lesional_day15 | 287.96 | 58 |
GSM1296039 | E_lesional_day15 | 348.49 | 62 |
GSM1296042 | H_lesional_day15 | 262.41 | 56 |
GSM1296043 | L_lesional_day15 | 246.71 | 54 |
GSM1296037 | M_lesional_day15 | 375.72 | 62 |
GSM1296046 | P_lesional_day15 | 313.44 | 59 |
GSM1296044 | Q_lesional_day15 | 286.71 | 57 |
GSM1296045 | Y_lesional_day15 | 272.6 | 56 |
GSM1296025 | C_lesional_day15 | 339.07 | 61 |
GSM1296033 | D_lesional_day15 | 309.18 | 59 |
GSM1296027 | I_lesional_day15 | 286.91 | 59 |
GSM1296032 | J_lesional_day15 | 221.44 | 54 |
GSM1296024 | K_lesional_day15 | 400.73 | 64 |
GSM1296031 | W_lesional_day15 | 204.89 | 52 |
GSM1296028 | X_lesional_day15 | 297.71 | 59 |
GSM1296029 | Z_lesional_day15 | 329.47 | 60 |
GSM1296026 | F_lesional_day15 | 344.08 | 62 |
GSM1296030 | O_lesional_day15 | 386.43 | 64 |
GSM1296040 | S_lesional_day15 | 300.83 | 59 |
GSM1296036 | T_lesional_day15 | 339.35 | 60 |
GSM1296048 | V_lesional_day15 | 345.44 | 61 |
GSM1296059 | A_lesional_day43 | 337.58 | 61 |
GSM1296066 | G_lesional_day43 | 236.28 | 54 |
GSM1296060 | R_lesional_day43 | 421.8 | 65 |
GSM1296063 | U_lesional_day43 | 325.81 | 60 |
GSM1296064 | E_lesional_day43 | 395 | 64 |
GSM1296067 | H_lesional_day43 | 292.78 | 57 |
GSM1296062 | M_lesional_day43 | 346.35 | 61 |
GSM1296068 | Q_lesional_day43 | 293.97 | 57 |
GSM1296050 | C_lesional_day43 | 265.28 | 57 |
GSM1296057 | D_lesional_day43 | 432.64 | 65 |
GSM1296052 | I_lesional_day43 | 282.38 | 59 |
GSM1296054 | J_lesional_day43 | 246.05 | 55 |
GSM1296049 | K_lesional_day43 | 316.25 | 60 |
GSM1296055 | W_lesional_day43 | 328.23 | 60 |
GSM1296053 | X_lesional_day43 | 179.56 | 51 |
GSM1296058 | Z_lesional_day43 | 397.78 | 64 |
GSM1296051 | F_lesional_day43 | 353.74 | 63 |
GSM1296056 | O_lesional_day43 | 493.9 | 68 |
GSM1296065 | S_lesional_day43 | 343.02 | 61 |
GSM1296061 | T_lesional_day43 | 362.55 | 62 |
GSM1296095 | A_non-lesional_pre-dose | 430.76 | 65 |
GSM1296120 | B_non-lesional_pre-dose | 311.7 | 59 |
GSM1296077 | C_non-lesional_pre-dose | 399.12 | 64 |
GSM1296093 | D_non-lesional_pre-dose | 228.84 | 54 |
GSM1296104 | E_non-lesional_pre-dose | 334.73 | 61 |
GSM1296079 | F_non-lesional_pre-dose | 266.74 | 58 |
GSM1296108 | G_non-lesional_pre-dose | 301.48 | 59 |
GSM1296110 | H_non-lesional_pre-dose | 229.57 | 53 |
GSM1296081 | I_non-lesional_pre-dose | 255.79 | 57 |
GSM1296091 | J_non-lesional_pre-dose | 265.3 | 58 |
GSM1296075 | K_non-lesional_pre-dose | 352.43 | 63 |
GSM1296112 | L_non-lesional_pre-dose | 237.37 | 53 |
GSM1296100 | M_non-lesional_pre-dose | 248.07 | 55 |
GSM1296087 | O_non-lesional_pre-dose | 323.15 | 61 |
GSM1296118 | P_non-lesional_pre-dose | 306.14 | 58 |
GSM1296114 | Q_non-lesional_pre-dose | 222.91 | 53 |
GSM1296097 | R_non-lesional_pre-dose | 301.32 | 59 |
GSM1296106 | S_non-lesional_pre-dose | 390.68 | 63 |
GSM1296102 | U_non-lesional_pre-dose | 354.59 | 61 |
GSM1296122 | V_non-lesional_pre-dose | 280.26 | 57 |
GSM1296089 | W_non-lesional_pre-dose | 155.98 | 47 |
GSM1296083 | X_non-lesional_pre-dose | 252.01 | 56 |
GSM1296116 | Y_non-lesional_pre-dose | 317.62 | 59 |
GSM1296085 | Z_non-lesional_pre-dose | 222.1 | 54 |